Skip to content
MedsAcross

Medicine

Nateglinide 60 mg tablet

Nateglinide · Oral
Available on requestPrescription onlyUS FDAGeneric name

Nateglinide 60 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20º to 25ºC (68º to 77ºF), excursions permitted between 15º to 30ºC…

Key facts

Active ingredient (INN)
Nateglinide
Brand
Sold under the generic name
Strength
60 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 25 more
Manufacturers
Zydus LifesciencesIndiaDr. Reddy's LaboratoriesIndiaCadila PharmaceuticalsIndiaStrides PharmaIndiaRising Pharma HoldingsModavar PharmaceuticalsAmerican Health PackagingGolden State Medical Supply
Origin register
US FDA, United States
Storage
Store at 20º to 25ºC (68º to 77ºF), excursions permitted between 15º to 30ºC (59º to 86ºF) Dispense in a tight container (USP).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A10BX03 Nateglinide
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
9 September 2009
Identifiers
RxCUI 311919, 314142DailyMed set ID af81465b-5f49-4eeb-8122-ef7fe5d90ddc, b41f4180-96a7-411d-b827-5021e534f556, 0ccf9b07-3c21-482d-abeb-a06ceb482c7b +6NDC 72241-002, 16571-758, 64380-167 +6Application ANDA206432, ANDA205544, ANDA077463 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle68382-721-01Zydus LifesciencesIndia27 October 2016
500 tablet, film coated in 1 bottle68382-721-05Zydus LifesciencesIndia27 October 2016
30 tablet, film coated in 1 bottle68382-721-06Zydus LifesciencesIndia27 October 2016
1000 tablet, film coated in 1 bottle68382-721-10Zydus LifesciencesIndia27 October 2016
90 tablet, film coated in 1 bottle68382-721-16Zydus LifesciencesIndia27 October 2016
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack68382-721-77Zydus LifesciencesIndia27 October 2016
1000 tablet, film coated in 1 bottle70771-1015-0Zydus LifesciencesIndia27 October 2016
100 tablet, film coated in 1 bottle70771-1015-1Zydus LifesciencesIndia27 October 2016
30 tablet, film coated in 1 bottle70771-1015-3Zydus LifesciencesIndia27 October 2016
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack70771-1015-4Zydus LifesciencesIndia27 October 2016
500 tablet, film coated in 1 bottle70771-1015-5Zydus LifesciencesIndia27 October 2016
90 tablet, film coated in 1 bottle70771-1015-9Zydus LifesciencesIndia27 October 2016
90 tablet, coated in 1 bottle71209-030-04Cadila PharmaceuticalsIndia17 December 2020
100 tablet, coated in 1 bottle71209-030-05Cadila PharmaceuticalsIndia10 February 2014
100 tablet in 1 bottle55111-328-01Dr. Reddy's LaboratoriesIndia9 September 2009
500 tablet in 1 bottle55111-328-05Dr. Reddy's LaboratoriesIndia9 September 2009
30 tablet in 1 bottle55111-328-30Dr. Reddy's LaboratoriesIndia9 September 2009
10 blister pack in 1 carton / 10 tablet in 1 blister pack55111-328-78Dr. Reddy's LaboratoriesIndia9 September 2009
90 tablet in 1 bottle55111-328-90Dr. Reddy's LaboratoriesIndia9 September 2009
100 tablet in 1 bottle, plastic64380-167-01Strides PharmaIndia9 May 2022
90 tablet in 1 bottle, plastic64380-167-02Strides PharmaIndia7 September 2022
90 tablet, coated in 1 bottle72241-002-04Modavar Pharmaceuticals19 August 2021
100 tablet, coated in 1 bottle72241-002-05Modavar Pharmaceuticals19 August 2021
100 tablet in 1 bottle16571-758-01Rising Pharma Holdings16 December 2020
90 tablet in 1 bottle16571-758-09Rising Pharma Holdings16 December 2020
500 tablet in 1 bottle16571-758-50Rising Pharma Holdings16 December 2020
30 blister pack in 1 carton / 1 tablet in 1 blister pack60687-673-21American Health Packaging12 January 2023
100 tablet in 1 bottle, plastic51407-656-01Golden State Medical Supply25 May 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 December 2000Drugs@FDA
EU (EMA)WithdrawnEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Nateglinide

Clinical summary

Nateglinide is a glinide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets for oral use. MedsAcross supplies Nateglinide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Nateglinide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Nateglinide 60 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.